Selenium nanoparticles involve HSP-70 and SIRT1 in preventing the progression of type 1 diabetic nephropathy

被引:111
|
作者
Kumar, Goru Santosh [1 ]
Kulkarni, Apoorva [1 ]
Khurana, Amit [1 ]
Kaur, Jasmine [1 ]
Tikoo, Kulbhushan [1 ]
机构
[1] NIPER, Dept Pharmacol & Toxicol, Lab Epigenet & Dis, Patiala 160062, Punjab, India
关键词
Diabetic nephropathy; Selenium nanoparticles; Apoptosis; HSP-70; NITRIC-OXIDE SYNTHASE; OXIDATIVE STRESS; PROTECTIVE ROLE; RENAL-DISEASE; VITAMIN-E; APOPTOSIS; EXPRESSION; DAMAGE; RATS; RESVERATROL;
D O I
10.1016/j.cbi.2014.09.017
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The present study was undertaken to examine the protective effect of selenium nanoparticles (SeNPs) in the progression of diabetic nephropathy (DN). Diabetes was induced in male Sprague Dawley (SD) rats by injecting streptozotocin (STZ) (55 mg/kg, i.p). DN was then assessed by measuring blood urea nitrogen (BUN), creatinine, albumin, fibronectin and collagen. Changes in the expression of cytoprotective and apoptotic proteins in the kidney of rats were also examined. Herein we show that SeNPs effectively lowered the levels of BUN, creatinine, fibronectin and collagen and elevated the levels of albumin in diabetic rats. Histological observation corroborated with the above protective effects of SeNPs. Interestingly, SeNPs elevated the levels of heat shock protein (HSP-70), longevity protein SIRT 1 and also modulated apoptotic proteins Bax and Bc1-2 in diabetic kidney. Our data represents a paradigm shift in our understanding about the therapeutic potential of SeNPs in preventing DN by not only quenching oxidative stress but also by activating cyto-protective protein HSP70 and longevity protein SIRT1. (C) 2014 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:125 / 133
页数:9
相关论文
共 50 条
  • [1] Tetrahydroxystilbene Involve HSP-70 and SIRT1 in Preventing the Progression of Diabetic Cardiomyopathy
    Gan, Shouyi
    Zeng, Lingyong
    Li, Cairong
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 66 (16) : C34 - C34
  • [2] SIRT1: Mechanism and Protective Effect in Diabetic Nephropathy
    Ji, Jing
    Tao, Pengyu
    Wang, Qian
    Li, Lingxing
    Xu, Yuzhen
    ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS, 2021, 21 (05) : 835 - 842
  • [3] Progression of diabetic nephropathy in type 1 diabetic patients
    Najafian, Behzad
    Mauer, Michael
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2009, 83 (01) : 1 - 8
  • [4] Hydrogen sulfide modulates SIRT1 and suppresses oxidative stress in diabetic nephropathy
    Hanan H. Ahmed
    Fatma M. Taha
    Heba S. Omar
    Heba M. Elwi
    Marwa Abdelnasser
    Molecular and Cellular Biochemistry, 2019, 457 : 1 - 9
  • [5] Hydrogen sulfide modulates SIRT1 and suppresses oxidative stress in diabetic nephropathy
    Ahmed, Hanan H.
    Taha, Fatma M.
    Omar, Heba S.
    Elwi, Heba M.
    Abdelnasser, Marwa
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2019, 457 (1-2) : 1 - 9
  • [6] Empagliflozin Ameliorates Kidney Injury in Diabetic Nephropathy via SIRT1 and TXNIP
    Liang, Riying
    Wang, Meijun
    Xu, Fen
    Cai, Mengyin
    DIABETES, 2020, 69
  • [7] Salidroside stimulates the Sirt1/PGC-1α axis and ameliorates diabetic nephropathy in mice
    Xue, Haiyan
    Li, Peipei
    Luo, Yishu
    Wu, Chuwen
    Liu, Yue
    Qin, Xiaogang
    Huang, Xinzhong
    Sun, Cheng
    PHYTOMEDICINE, 2019, 54 : 240 - 247
  • [8] Progression of diabetic nephropathy in normotensive type 1 diabetic patients
    Jacobsen, P
    Rossing, K
    Tarnow, L
    Rossing, P
    Mallet, C
    Poirier, O
    Cambien, F
    Parving, HH
    KIDNEY INTERNATIONAL, 1999, 56 : S101 - S105
  • [9] Smoking and progression of diabetic nephropathy in type 1 diabetes
    Hovind, P
    Rossing, P
    Tarnow, L
    Parving, HH
    DIABETES CARE, 2003, 26 (03) : 911 - 916
  • [10] Smoking and progression of diabetic nephropathy in Type 1 diabetes
    Hovind, P
    Rossing, P
    Tarnow, L
    Parving, HH
    DIABETOLOGIA, 2002, 45 : A361 - A361